School of Medicine
Showing 1-10 of 16 Results
-
Paul A. Khavari, MD, PhD
Carl J. Herzog Professor of Dermatology in the School of Medicine
Current Research and Scholarly InterestsWe work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.
-
Phuong Khuu, MD
Clinical Assistant Professor, Dermatology
BioPhuong Khuu, M.D., is a Clinical Assistant Professor in Pediatric Dermatology at Lucile Packard Children’s Hospital. Her clinical interests include children with complex dermatologic diseases and epidermolysis bullosa. Her research interest is in clinical management of epidermolysis bullosa.
-
Nour Kibbi, MD, FAAD
Clinical Assistant Professor, Dermatology
BioDr. Kibbi is a board-certified dermatologist and fellowship-trained dermatologic surgeon. Her clinical interests include Mohs micrographic surgery for skin cancer and laser and injectable treatments to combat aging, sun-damaged skin, and other indications. Her research interests include rare skin tumors, challenging lip lesions, non-invasive treatments, such as photodynamic therapy for non-melanoma skin cancer, and cosmetic procedures for acne scars and autoimmune conditions. Her work has appeared at national and international meetings and has been published in peer-reviewed journals, including Lancet Oncology, Journal of the American Academy of Dermatology, British Journal of Dermatology, Journal of Dermatologic Surgery.
-
James Michael Kilgour
Affiliate, Department Funds
Resident in DermatologyBioJames grew up in Oxford in the United Kingdom. He graduated from Cardiff University School of Medicine with honours in 2017, and has a BSc in Medical Education. Following graduation, he completed two years as a clinical academic in Dermatology at the University of Oxford, conducting research investigating patient-reported outcome measures and quality of life in patients with Graft-versus-Host-Disease following allogenic stem cell transplant. He subsequently completed a two year precision medicine fellowship at the Stanford University Department of Dermatology, focusing on cutaneous oncology and hidradenitis suppurativa. He has also extensively published in medical education, and co-founded a novel peer reviewed medical journal targeted at encouraging medical students to publish and peer review. He is currently completing his residency in Dermatology at Stanford.
-
Jiyeong Kim
Postdoctoral Scholar, Dermatology
BioDr. Jiyeong Kim is a post-doctoral scholar at the Stanford Center for Digital Health and the Department of Dermatology School of Medicine. As a multi-disciplined data scientist, Dr. Kim applies artificial intelligence (AI) to clinical informatics, harnessing patient-generated health information and data to enhance patient-centered care, which could be tailored to each patient group for improving patient engagement and better health outcomes. In her work, Dr. Kim leverages large language models, machine learning, and natural language processing to understand patients' and caregivers' genuine voices of care needs and needed support for individuals with chronic diseases, not limited to diabetes, cardiovascular disease, and cancer.
Research Interest
-LLMs and Generative AI to Listen to the Patient
-Generative AI-Assisted Enhanced Patient Care
-ML-based Disease Prediction Modeling
-Patient-Generated Data and Precision Health -
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Justin M Ko, MD, MBA
Clinical Professor, Dermatology
BioDr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including as an Associate Chief Quality Officer and physician dyadic partner to the Chief Experience Offer, as well as co-chair of the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care and is a founder and leader of the Stanford Translational AI in Dermatology (TRAIND) group. He chairs the American Academy of Dermatology's Committee on Augmented Intelligence.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is a founder and co-director of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident.